Kyowa Hakko Kirin Obtains Migraine Indication For Epilepsy Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare granted Kyowa Hakko Kirin's Depakene (valproate) an additional indication to treat migraines in Japan